Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 8021–8040 of 17,773 recalls
Oxalis Labs
Defective Container; complaints of leakage.
MAJOR PHARMACEUTICALS
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer